IS4570A - Imidazo [1,2-a] pyridine derivatives - Google Patents

Imidazo [1,2-a] pyridine derivatives

Info

Publication number
IS4570A
IS4570A IS4570A IS4570A IS4570A IS 4570 A IS4570 A IS 4570A IS 4570 A IS4570 A IS 4570A IS 4570 A IS4570 A IS 4570A IS 4570 A IS4570 A IS 4570A
Authority
IS
Iceland
Prior art keywords
imidazo
pyridine derivatives
pyridine
derivatives
Prior art date
Application number
IS4570A
Other languages
Icelandic (is)
Inventor
John Beswick Paul
Baxter Campbell Ian
Naylor Alan
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9506965.4A external-priority patent/GB9506965D0/en
Priority claimed from GBGB9512099.4A external-priority patent/GB9512099D0/en
Priority claimed from GBGB9516117.0A external-priority patent/GB9516117D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4570A publication Critical patent/IS4570A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4570A 1995-04-04 1997-09-25 Imidazo [1,2-a] pyridine derivatives IS4570A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9506965.4A GB9506965D0 (en) 1995-04-04 1995-04-04 Chemical compounds
GBGB9512099.4A GB9512099D0 (en) 1995-06-14 1995-06-14 Chemical compounds
GBGB9516117.0A GB9516117D0 (en) 1995-08-05 1995-08-05 Chemical compounds
PCT/EP1996/001438 WO1996031509A1 (en) 1995-04-04 1996-04-02 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES

Publications (1)

Publication Number Publication Date
IS4570A true IS4570A (en) 1997-09-25

Family

ID=27267657

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4570A IS4570A (en) 1995-04-04 1997-09-25 Imidazo [1,2-a] pyridine derivatives

Country Status (17)

Country Link
EP (1) EP0819127A1 (en)
JP (1) JPH11501049A (en)
KR (1) KR19980703559A (en)
CN (1) CN1186492A (en)
AU (1) AU5276696A (en)
BG (1) BG101934A (en)
CA (1) CA2216809A1 (en)
CZ (1) CZ313397A3 (en)
EA (1) EA199700209A1 (en)
HU (1) HUP9801602A3 (en)
IS (1) IS4570A (en)
NO (1) NO974595L (en)
NZ (1) NZ304886A (en)
PL (1) PL322623A1 (en)
SK (1) SK133297A3 (en)
TR (1) TR199701105T1 (en)
WO (1) WO1996031509A1 (en)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764292B1 (en) * 1997-06-10 2000-12-29 Innothera Lab Sa USE OF DICETONIC TETRACYCLE DERIVATIVES, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPEUTICS
US6307047B1 (en) 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
ATE281458T1 (en) * 1997-09-05 2004-11-15 Glaxo Group Ltd PHARMACEUTICAL COMPOSITION CONTAINING 2,3-DIARYL-PYRAZOLO(1,5-B)PYRIDAZINE DERIVATIVES
FR2770131A1 (en) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Analgesic combinations of a cyclooxygenase-2 inhibitor and acetaminophen or an opiate having synergistic activity
FR2771005B1 (en) * 1997-11-18 2002-06-07 Union Pharma Scient Appl NEW PHARMACEUTICAL ASSOCIATION WITH ANALGESIC ACTIVITY
GB9810920D0 (en) * 1998-05-21 1998-07-22 Merck Sharp & Dohme Therapeutic use
ES2140354B1 (en) * 1998-08-03 2000-11-01 S A L V A T Lab Sa IMIDAZO (1,2A) AZINAS SUBSTITUTED AS SELECTIVE INHIBITORS OF COX-2.
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives
ATE275148T1 (en) * 1998-11-03 2004-09-15 Glaxo Group Ltd PYRAZOLOPYRIDINE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS
WO2000052008A1 (en) * 1999-02-27 2000-09-08 Glaxo Group Limited Pyrazolopyridines
CO5261556A1 (en) 1999-12-08 2003-03-31 Pharmacia Corp CYCLLOXYGENASE-2 INHIBITING COMPOSITIONS THAT HAVE FAST THERAPEUTIC EFFECT ACCESS
GB9930358D0 (en) 1999-12-22 2000-02-09 Glaxo Group Ltd Process for the preparation of chemical compounds
JP2003523958A (en) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド Inhibitors, compositions and uses of nitrosated and nitrosylated cyclooxygenase-2
GB0002312D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
PE20011333A1 (en) 2000-03-16 2002-01-16 Almirall Prodesfarma Ag DERIVATIVES OF 2-FENYLPYRAN-4-ONA AS INHIBITORS OF CYCLOOXYGENASE 2
PE20020146A1 (en) * 2000-07-13 2002-03-31 Upjohn Co OPHTHALMIC FORMULATION INCLUDING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR
NZ524252A (en) 2000-07-20 2004-03-26 Lauras As Cox-2 inhibitors for treating HIV and AIDS
PE20020506A1 (en) 2000-08-22 2002-07-09 Glaxo Group Ltd PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS
GB0025449D0 (en) * 2000-10-17 2000-11-29 Glaxo Group Ltd Chemical compounds
ES2245380T3 (en) 2000-12-15 2006-01-01 Glaxo Group Limited PIRAZOLOPIRIDINAS.
EP1377573B1 (en) 2000-12-15 2005-07-27 Glaxo Group Limited Pyrazolopyridine derivatives
US7153855B2 (en) 2001-03-08 2006-12-26 Smithkline Beecham Corporation Pyrazolopyridinyl pyrimidine therapeutic compounds
EP1372643A1 (en) 2001-03-30 2004-01-02 Smithkline Beecham Corporation Pyrazolopyridines, process for their preparation and use as therapeutic compounds
PE20021017A1 (en) 2001-04-03 2002-11-24 Pharmacia Corp RECONSTITUABLE PARENTERAL COMPOSITION
JP4219171B2 (en) 2001-04-10 2009-02-04 スミスクライン ビーチャム コーポレーション Antiviral pyrazolopyridine compounds
US6756498B2 (en) 2001-04-27 2004-06-29 Smithkline Beecham Corporation Process for the preparation of chemical compounds
AU2002305143A1 (en) 2001-04-27 2002-11-11 Smithkline Beecham Corporation Pyrazolo'1,5-a!pyridine derivatives
KR20040018281A (en) 2001-06-21 2004-03-02 스미스클라인 비참 코포레이션 Imidazo‘1,2-α!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
AR038957A1 (en) 2001-08-15 2005-02-02 Pharmacia Corp COMBINATION THERAPY FOR CANCER TREATMENT
US7244740B2 (en) 2001-10-05 2007-07-17 Smithkline Beecham Corporation Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
GB0124931D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124939D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124936D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124941D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124938D0 (en) 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
WO2003050120A1 (en) 2001-12-11 2003-06-19 Smithkline Beecham Corporation Pyrazolo-pyridine derivatives as antiherpes agents
CN100369898C (en) 2002-02-12 2008-02-20 史密丝克莱恩比彻姆公司 Nicotinamide derivatives useful as p38 inhibitors
JP2005535642A (en) 2002-06-28 2005-11-24 ニトロメッド インコーポレーティッド Nitrosated and / or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use containing oximes and / or hydrazones
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
WO2004033454A1 (en) 2002-10-03 2004-04-22 Smithkline Beecham Corporation Therapeutic compounds based on pyrazolopyridine derivatives
KR20040072004A (en) 2003-02-07 2004-08-16 삼성에스디아이 주식회사 Emitting compound for electroluminescence device and device using thereof
GB0308201D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308186D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0308185D0 (en) 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
PT1534305E (en) 2003-05-07 2007-02-28 Osteologix As Treating cartilage / bone conditions with water-soluble strontium salts
GB0318814D0 (en) 2003-08-11 2003-09-10 Smithkline Beecham Corp Novel compounds
US8067464B2 (en) 2004-10-04 2011-11-29 Nitromed, Inc. Compositions and methods using apocynin compounds and nitric oxide donors
US20090018091A1 (en) 2005-08-02 2009-01-15 Nitromed, Inc. Nitric Oxide Enhancing Antimicrobial Compounds, Compositions and Methods of Use
CA2647859C (en) 2006-03-29 2016-01-05 Nitromed, Inc. Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
US7750007B2 (en) 2006-11-06 2010-07-06 Supergen, Inc. Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors
DK2734205T3 (en) 2011-07-21 2018-06-14 Tolero Pharmaceuticals Inc Heterocyclic Protein Kinase Inhibitors
WO2016177776A1 (en) 2015-05-04 2016-11-10 Academisch Medisch Centrum Biomarkers for the detection of aspirin insensitivity
HUE072069T2 (en) 2019-02-12 2025-10-28 Sumitomo Pharma America Inc Crystalline form of the hydrochloride salt of 2-((1r,4r)-4-((3-(3-(trifluoromethyl)phenyl) imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol
IL305573A (en) 2021-03-15 2023-10-01 Saul Yedgar Hyaluronic acid conjugated with dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment or suppression of inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455924A (en) * 1967-02-08 1969-07-15 Upjohn Co Dianisylimidazoles

Also Published As

Publication number Publication date
CN1186492A (en) 1998-07-01
NO974595L (en) 1997-12-03
KR19980703559A (en) 1998-11-05
CA2216809A1 (en) 1996-10-10
WO1996031509A1 (en) 1996-10-10
EP0819127A1 (en) 1998-01-21
CZ313397A3 (en) 1998-03-18
EA199700209A1 (en) 1998-04-30
NZ304886A (en) 1998-11-25
PL322623A1 (en) 1998-02-02
AU5276696A (en) 1996-10-23
HUP9801602A3 (en) 1999-01-28
NO974595D0 (en) 1997-10-03
MX9707379A (en) 1997-11-29
BG101934A (en) 1999-04-30
SK133297A3 (en) 1998-07-08
JPH11501049A (en) 1999-01-26
TR199701105T1 (en) 1998-02-21
HUP9801602A2 (en) 1998-11-30

Similar Documents

Publication Publication Date Title
AU5276696A (en) Imidazo{1,2-a}pyridine derivatives
EE200200080A (en) Imidazo [1,2a] pyridine and pyrazolo [2,3a] pyridine derivatives
DE69804273D1 (en) 5h-thiazolo [3,2-a] pyrimidine derivatives
DE69529777D1 (en) 2-benzylthio-8-amino (1,2,4) triazolo (1,5-a) pyridine
MX9202838A (en) IMIDAZO [1,5-A] QUINOXALINAS.
DE69800896D1 (en) 8-substituted-1,3,8-triazaspiro [4,5] decan-4-one derivatives
IL117824A0 (en) Use of imidazo [1,2-alpha] pyridine-3-acetamide derivatives
FI961564A7 (en) Alkoxyalkylcarbamates of imidazo(1,2-a)pyridines
DE69803653D1 (en) 1,3,8-triazaspiro [4,5] decan-4-one derivatives
PT837860E (en) 5,6-DIHYDRO-9H-PYRAZOLO-3,4-C | -1,2,4-TRIAZOLO-4,3-ALPHA | TRYCYLIC PYRIDINES
DE59009117D1 (en) [1,2,4] triazolo [1,5-a] pyridines.
AU698867B2 (en) Fused imidazo 1,2-a pyridines
DE69502542D1 (en) 2-phenyl-7-chloro-perhydroimidazo (1,5-a) pyridine
NO982843D0 (en) 2,7-Substituted octahydro-pyrrole £ 1,2-apyrazine derivatives
DE69824872D1 (en) 1,2,3,4-TETRAHYDRO-BENZOFURO [3,2-C] PYRIDINE DERIVATIVES
AU2253297A (en) Imidazo{1,2-a}pyridine c-nucleosides as antiviral agents
FI971310L (en) 2,7-substituted octahydro-1H-pyrido/1,2-a/pyrazine derivatives
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
FI943999A7 (en) Pyrido(1,2,3-d,e)(1,3,4)benzoxadiazine derivatives
DE69515498D1 (en) NAPHTHYRIDINE DERIVATIVES
BR9609892A (en) Imidazopyridine derivatives
FI970827L (en) New thiazolo 3,2-a/quinoline and -naphthyridine derivatives
AU2984695A (en) 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)-one derivatives as nmda antagonists
ZA966559B (en) Imidazopyridine derivatives.
IL121360A0 (en) Imidazopyridine derivatives